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Abstract  22 
The aetiology of many gestational disorders is still unknown. However, insufficient trans-23 
placental nutrient and oxygen transfer due to abnormal placentation is characteristic of 24 
several pathologies, and may alter the function of placental mitochondria. Mitochondria are 25 
multifunctional organelles that respond to a wide range of stimuli – such as physiological 26 
changes in cellular energy demands or various pathologies – by reshaping via fusion or 27 
fission, increasing/decreasing in number, altering oxidative phosphorylation, and signalling 28 
cellular functions such as apoptosis.  Mitochondrial function is integral to tissue functions 29 
including energy production, metabolism, and regulation of various cellular responses 30 
including response to oxidative stress. This review details the functions of placental 31 
mitochondria and investigates mitochondrial function and structure in gestational disorders 32 
including preeclampsia, intrauterine growth restriction, diabetes mellitus, and obesity. 33 
Placental mitochondrial dysfunction may be critical in a range of gestational disorders which 34 
have important implications for maternal and fetal/offspring health.  35 
 36 
Keywords: mitochondria; oxidative stress; preeclampsia; intrauterine growth restriction; 37 
diabetes; obesity 38 
  39 
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1. Introduction 40 
 41 
Mitochondria originated from the symbiosis of primordial eukaryotic cells and aerobic 42 
bacteria. Mitochondria, which contain their own genome (mtDNA) and machinery to 43 
synthesise RNA and proteins, work in concert with the nuclear genome and other organelles. 44 
Almost all cellular energy is produced through oxidative phosphorylation in mitochondria; 45 
partnered redox reactions transfer electrons through oxygen to water and pump protons into 46 
the mitochondrial inner membrane through respiratory complexes (complexes I, III, and IV). 47 
The electrochemical gradient created by the transfer of protons is termed mitochondrial 48 
membrane potential (∆Ψm), and is harnessed by ATP synthase (complex V) to generate ATP. 49 
Mitochondria are known as the powerhouses of the cell due to their central role in ATP 50 
generation. However, mitochondria have several additional functions; they provide important 51 
signalling on cellular homeostasis, and are key regulators of cell fate through 52 
autophagy/apoptosis. Mitochondria form a dynamic reticulum, and the reshaping of this 53 
reticulum in response to differences in mitochondrial membrane potential helps control 54 
mitochondrial and cellular fate (Figure 1). In conjunction with the endoplasmic reticulum, 55 
mitochondria can regulate mediators of cell death such as calcium levels and caspases. 56 
Additionally, in the placenta and other tissues such as the adrenal glands, mitochondria are 57 
crucial to the production of steroids [1, 2].  58 
 59 
Mitochondrial dysfunction is thought to contribute to a wide range of disorders related to 60 
oxidative stress, such as cardiovascular disease, type 2 diabetes, and neurodegenerative 61 
disorders. Partial occlusion of blood flow leading to local hypoxia is a common feature in 62 
several pathologies which show effects on the mitochondria. Mitochondria consume oxygen 63 
to generate ATP via oxidative phosphorylation, producing reactive oxygen species (ROS) as 64 
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a by-product. Oxygen variability can lead to oxidative stress when there is a 65 
disproportionately high production of ROS in comparison to antioxidants [3, 4]. 66 
Mitochondria are susceptible to damage by these free radicals, which may result in alterations 67 
in their structure and function [5]. 68 
 69 
Pregnancy itself is characterised by increased oxidative stress, which is often heightened in 70 
disorders. Of relevance to this review, increased placental oxidative stress is a feature of 71 
several gestational pathologies including preeclampsia, intrauterine growth restriction 72 
(IUGR), maternal diabetes, and maternal obesity [6]. Preeclampsia and IUGR are associated 73 
with reduced placental perfusion, potentially leading to oxygen deprivation [7]. Placentae 74 
afflicted by maternal diabetes and/or obesity are exposed to a range of insults, including high 75 
glucose and fatty acid levels as well as inflammatory mediators. These insults may lead to 76 
abnormal function of the uteroplacental unit, including impaired placentation [8]. As a 77 
number of pregnancy pathologies share a mutual phenotype of restricted or heightened 78 
variability in placental oxygen supply [9], which is likely to alter mitochondrial structure and 79 
function [10, 11], placental mitochondria may be aetiologically important in several 80 
pregnancy pathologies.  81 
 82 
This review details important features of placental mitochondria and summarises evidence on 83 
how placental mitochondria are affected in a range of pregnancy disorders. Gaining a greater 84 
appreciation of mitochondrial content, structure, and function in the placenta provides an 85 
opportunity to explore interventional avenues. 86 
 87 
2. Mitochondria reactive oxygen species 88 
 89 
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Oxidative stress mediated by ROS is a common feature of several gestational disorders. 90 
Mitochondria are the main sites of ROS generation, and are also susceptible to ROS-mediated 91 
damage. The generation of ROS result from the transfer of a single electron from a redox 92 
donor to molecular oxygen, yielding superoxide which can be converted to hydrogen 93 
peroxide by superoxide dismutase. This often occurs when oxygen reacts with electrons 94 
generated by complex I and III but can also occur at complex II of the electron transport 95 
chain [12]. Approximately 0.15–4% of oxygen in mitochondria produces ROS [13]. 96 
Hydrogen peroxide can alter protein structure and function through altering the redox state of 97 
thiol moieties in sensitive proteins [14].The amount of ROS produced is dependent on 98 
mitochondrial characteristics such as activity level and dynamics as well as the type and 99 
amount of available fuel (carbohydrate, lipid, or amino acid) [15].  100 
 101 
The production of ROS is physiological and ROS regulate many cellular functions including 102 
autophagy, anti-microbial effects, and act as signalling molecules in many pathways 103 
including cellular differentiation and inflammation [16]. ROS production also regulates 104 
mitochondrial fission and fusion in healthy cells, providing a mechanism that regulates 105 
mitochondrial morphology and function that is dependent on the redox state [17]. Excessive 106 
ROS production can, however, be detrimental to cellular function, causing oxidative damage 107 
to DNA, proteins and (membrane) lipids, which is associated with hypertension and insulin 108 
resistance [5]. Chronic oxidative stress can also lead to changes characteristic of senescence, 109 
and senescence of the syncytiotrophoblast may be a feature of the normal progression of 110 
pregnancy which is exaggerated in pathologies [18]. In the endothelium, excessive ROS 111 
production can affect vasodilation through the inhibition of the expression and function of 112 
endothelial nitric oxide synthase [19]. This regulatory effect of ROS on vasodilation may be 113 
involved in the pathogenesis of preeclampsia [20]. 114 
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 115 
3. Mitochondrial regulation of apoptosis  116 
 117 
Mitochondria are key signalling organelles due to their responsiveness to the metabolic 118 
functioning of the cell. The interactions between mitochondria and the endoplasmic reticulum 119 
are critical to cell homeostasis and signalling (reviewed by [18]). Mitochondria can initiate 120 
apoptosis by the release of mitochondrial intermembrane space proteins such as cytochrome c 121 
into the cytoplasm through mitochondrial membrane permeabilization or rupture [21]. An 122 
early event in the initiation of apoptosis is the opening of the mitochondrial permeability 123 
transition pore and subsequent swelling of the mitochondrial matrix leading to rupture [21].  124 
 125 
Swelling of mitochondria characteristic of apoptosis has been reported in isolated 126 
preeclamptic placental mitochondria [22] and similar morphological alterations of placental 127 
mitochondria are found in instances of gestational diabetes mellitus (GDM) [23]. Further, 128 
mitochondrial size appears to be reduced in preeclampsia [24], and the levels of many 129 
apoptotic proteins are altered in preeclamptic placentae [25]. In vivo or in vitro treatments 130 
with preeclampsia-associated factors have been shown to alter placental mitochondria and 131 
potentially lead to some of the perturbations seen in preeclampsia. An increase in soluble 132 
fms-like tyrosine kinase 1 (sFlt-1) is found in the maternal circulation in preeclampsia, and is 133 
thought to be involved in the inhibition of angiogenesis by reducing the circulating levels of 134 
proangiogenic factors such as vascular endothelial growth factor [26]. The administration of 135 
sFlt-1 to pregnant mice led to features characteristic of preeclampsia (hypertension and 136 
proteinuria), as well as increased oxidative stress, swollen mitochondria, and increased 137 
apoptosis in the placentae [27]. The authors suggest that sFlt-1 is involved in increased 138 
oxidative stress and the activation of the mitochondrial apoptotic pathway [27]. 139 
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Antiphospholipid antibodies (aPLs) are an important maternal predisposing factor for the 140 
development of preeclampsia, although their mechanism of action is not well understood [28-141 
30]. c [31]. In vitro studies have demonstrated that aPLs are internalised by the 142 
syncytiotrophoblast and lead to multiple effects on syncytiotrophoblast mitochondria, 143 
including increased release of cytochrome c, depressed respiration, and changes in the 144 
expression of mitochondrial/apoptotic proteins [29]. Therefore, aPLs may primarily affect 145 
placental mitochondria, leading to the aberrant placental cell death and subsequent maternal 146 
immune activation that is characteristic of preeclampsia [32]. Further, rats exposed to a food-147 
restricted diet exhibited increased expression of pro-apoptotic proteins and cytochrome c 148 
release, indicating that maternal undernutrition also enhances mitochondria-dependent 149 
apoptosis in the placenta [33]. Therefore, multiple perturbations can lead to dysfunction of 150 
placental mitochondria and the induction of apoptosis. 151 
 152 
It should be noted that although the role of mitochondria in apoptosis is well characterised in 153 
many tissues, the progression of apoptosis in the syncytiotrophoblast is not fully understood. 154 
The syncytiotrophoblast lacks cell borders, and it has been suggested that apoptosis cannot 155 
progress in a syncytium as in mononuclear cells because of the danger of continued 156 
uncontrolled cell death [18].The pro-apoptotic proteins, p53, BCL2 associated X apoptosis 157 
regulator, and cytochrome c, have been reported to be decreased in syncytiotrophoblast 158 
mitochondria relative to the cytotrophoblast mitochondria from which they are derived [34]. 159 
Further, apoptosis is an active process requiring energy, and syncytiotrophoblast 160 
mitochondria appear to have reduced metabolic efficacy and ATP production [34]. Therefore, 161 
mitochondria in the syncytiotrophoblast may not regulate apoptosis in the same manner as 162 
other cell lineages. 163 
 164 
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4. Mitochondrial content  165 
 166 
Cells contain multiple mitochondria arranged in a dynamic interconnected reticulum. The 167 
mitochondrial content or mass in cells is plastic and able to respond to a wide variety of 168 
stimuli such as caloric restriction, increased energy demands, and various disease states [35-169 
38]. In the placenta, pregnancy pathologies related to placental insufficiency including IUGR 170 
and preeclampsia, as well as maternal diabetes and obesity, are associated with changes in 171 
mitochondrial content (Table 1). Further, levels of mtDNA in the maternal circulation can be 172 
increased in preeclampsia and placental abruption, and this material is likely to be derived 173 
from the placenta [39, 40]. A common feature of these conditions is increased oxidative 174 
stress. Hypoxic conditions are thought to occur in IUGR due to placental insufficiency and 175 
the subsequent reduction in placental blood flow [41]. Hypoxic stress can stimulate 176 
mitochondrial biogenesis and lead to increased mitochondrial content [11, 42, 43].This 177 
protective mechanism may help meet metabolic demands by increasing the bioenergetic 178 
capacity of the tissue. Lower pO2 levels have been found in both the umbilical vein and artery 179 
in IUGR, indicative of a hypoxic fetal environment [44]. 180 
 181 
Mitochondrial content was found to be decreased or increased in the same pregnancy 182 
pathology by different studies (Table 1). In cardiac tissue, decreased mitochondrial content 183 
has been linked to ischemic insult and related tissue damage [45]. Conversely, increased 184 
mitochondrial content has been associated with hypoxia and oxidative stress in cardiac, 185 
pulmonary, hepatic, and neuronal cells [42, 46, 47]. In pathologies, proliferation of 186 
mitochondria is thought to occur as a compensatory mechanism for the disruption of cellular 187 
bioenergetics [42, 48]. However, increased placental mitochondrial ROS may directly 188 
damage mtDNA, thus inhibiting the adaptive biogenesis of the self-replicating mitochondria 189 
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and reducing respiratory activity [49]. The apparent differences in response within the same 190 
pathologies may be linked to the severity or timing of the insult and the subsequent ability of 191 
the tissue to adapt through increased mitochondrial content. Either increased or decreased 192 
mitochondrial biogenesis could occur in an attempt to maintain normal fetal growth, with the 193 
effect depending on whether there is a compensatory response to increase energy output in 194 
nutritionally perturbed environments [44, 50, 51]. Vishnyakova et al. (2016) found increased 195 
placental mitochondrial content (mtDNA relative to nDNA) in early-onset but not late-onset 196 
preeclampsia, suggesting that the different pathophysiology leads to differences in 197 
mitochondrial response [52].  198 
 199 
In the majority of placental investigations, tissue as a whole has been considered. However, 200 
mitochondria within different cell lineages often have distinct functions and are likely to 201 
respond differently to stimuli. In particular, mitochondria within two of the major placental 202 
cell types, cytotrophoblasts and the syncytiotrophoblast, have very different structure and 203 
roles [34, 53]. Further, the antioxidant capacity of different regions of the placenta is varied, 204 
meaning that their ability to respond to hypoxia/reperfusion will be different [54]. In IUGR, 205 
Mando et al. (2014) found increased mitochondrial content in whole tissue but decreased 206 
content in cytotrophoblasts, indicating that the increased placental mitochondrial content is 207 
due to other cell lineages. The syncytiotrophoblast is in direct contact with maternal blood 208 
and has been suggested to be the cell type most affected in IUGR and preeclampsia [55]. The 209 
syncytiotrophoblast possess low levels of antioxidant enzymes, and mitochondria with 210 
reduced membrane potential and increased hydrogen peroxide production compared to the 211 
cytotrophoblasts which fuse to form the syncytiotrophoblast [34, 54]. Therefore, 212 
syncytiotrophoblast mitochondria may be more affected by hypoxia/reperfusion and could be 213 
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the source of the increased mitochondrial content; however, the mechanisms regulating 214 
mitochondrial dynamics in the syncytiotrophoblast are not well characterised.  215 
 216 
Mitochondrial biogenesis is controlled by multiple transcription factors which include nuclear 217 
respiratory factor 1 (NRF1), mitochondrial transcription factor A (TFAM), B1 (TFB1M), and 218 
B2 (TFB2M) (Figure 2). In addition, the co-activator peroxisome proliferator activated 219 
receptor γ coactivator-1 alpha (PGC-1α) is an important stimulator of mitochondrial 220 
transcription. PGC-1α stimulates mitochondrial biogenesis through the induction of NRF1, 221 
which in turn increases TFAM. Mitochondrial transcription factors TFB1M and TFB2M also 222 
interact with TFAM and mitochondrial RNA polymerase to support transcription [56]. 223 
Several studies have linked mitochondrial biogenesis transcription factors to placental 224 
mitochondrial content or pathology. In placentae with IUGR and/or preeclampsia where 225 
mitochondrial content was reduced, mRNA expression of PGC-1α and NRF1 was also 226 
decreased [51, 57]. Where IUGR was shown to increase mitochondrial content, NRF1 227 
expression was also increased [51]. Further, maternal caloric restriction in a rodent IUGR 228 
model leads to increased placental mitochondria content and the upregulation of biogenesis 229 
markers [58], whereas PGC-1α appears to be decreased in the placentae of rats subjected to 230 
reduced uterine perfusion pressure [59]. 231 
 232 
The regulation of mitochondrial dynamics occurs though mitochondrial biogenesis, and 233 
continuous cycles of fission and fusion. These processes are thought to target 234 
damaged/depolarized mitochondria for autophagy [60]. Vishnyakova et al. (2016) reported 235 
increased mitochondrial content in preeclamptic placentae without increased NRF1, as well 236 
as lower TFAM protein expression. However,  there was a significant increase in the 237 
mitochondrial fusion regulator, optic atrophy 1 mitochondrial dynamin like GTPase (OPA1), 238 
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suggesting mitochondrial fusion as a mechanism for increased content, potentially by 239 
stabilisation of mitochondrial structures [52]. Indeed, overexpression of OPA1 protects from 240 
ischemia in the heart and brain, and ROS production, cytochrome c release, and apoptosis 241 
[61]. 242 
 243 
5. Syncytiotrophoblast mitochondria  244 
 245 
As well as generating cellular energy in the form of ATP from oxidative phosphorylation, 246 
mitochondria are important in the synthesis of steroid hormones (reviewed in the placenta by 247 
[2]). In the human placenta, the syncytiotrophoblast forms the interface between maternal and 248 
fetal systems. Progesterone synthesised by the syncytiotrophoblast from maternally-derived 249 
cholesterol is central to the establishment and maintenance of the pregnancy. Progesterone 250 
functions in modulation of the endometrium and maternal immune response to fetal factors, 251 
and decreased progesterone levels are associated with spontaneous abortion/miscarriage [62]. 252 
The multinucleate syncytiotrophoblast is formed by the fusion of underlying mononuclear 253 
cytotrophoblasts. During differentiation into the syncytiotrophoblast, mitochondria appear to 254 
become highly specialised for steroidogenesis.  255 
 256 
The production of progesterone requires the transport of cholesterol to the mitochondria and 257 
cleavage of the cholesterol side-chain. Unlike the mitochondria of cytotrophoblasts, 258 
syncytiotrophoblast mitochondria contain high levels of cytochrome P450scc [53], which is 259 
responsible for the conversion of cholesterol into pregnenolone in the inner mitochondrial 260 
membrane. Therefore, mitochondria acquire steroidogenic ability during the formation of the 261 
syncytiotrophoblast. Steroidogenesis requires mitochondrial contact sites involving multi-262 
protein systems, where outer and inner membranes are in close proximity. In other 263 
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steroidogenic tissues (e.g. adrenal glands and gonads), intracellular transport of cholesterol to 264 
the mitochondria is regulated via the mitochondrial sterol carrier protein steroidogenic acute 265 
regulatory protein (StAR) [1, 2]. StAR is not expressed in the placenta and it has been 266 
suggested that the regulation of steroidogenesis is through the structurally-related protein 267 
StAR related lipid transfer domain containing 3 (STARD3; MLN64) [1, 2, 53]. In addition, 268 
the mitochondrial heat shock protein (HSP) HSP60 has been shown to associate with 269 
STARD3 in the placenta and may participate in steroidogenesis [63]. HSP have known 270 
functions in the cellular response to stress, often as chaperones; however, HSP can have 271 
additional roles. Antibodies against HSP60 are associated with various autoimmune 272 
conditions and increased serum cholesterol in atherosclerosis, indicating that HSP60 may 273 
have a role in cholesterol transport [63-65]. Therefore, cholesterol transport in placental 274 
mitochondria appears to utilise tissue-specific systems. 275 
 276 
Syncytiotrophoblast mitochondria are smaller and more irregular in shape than those of the 277 
cytotrophoblasts, and also have atypical cristae morphology (Figure 3), potentially through 278 
reduced dimerization of ATP synthase which helps to form mitochondrial architecture [53, 279 
66]. It has been suggested that these morphological changes are related to steroidogenesis, as 280 
cholesterol could be more efficiently transported to P450scc in the inner mitochondrial 281 
membrane in smaller mitochondria [66].  282 
 283 
Syncytiotrophoblast mitochondria have been reported to have a reduced coupling control of 284 
oxidative phosphorylation to ATP production in comparison to cytotrophoblast mitochondria, 285 
as well as reduced cardiolipin content, which is important in efficient oxidative 286 
phosphorylation [34]. Syncytiotrophoblast mitochondria also have reduced membrane 287 
potential and increased levels of hydrogen peroxide [34]. P450scc, which is present in high 288 
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levels in the syncytiotrophoblast, is involved in superoxide generation and may be source of 289 
oxygen radicals in syncytiotrophoblast mitochondria [34, 67]. 290 
 291 
The fusion of cytotrophoblasts into a syncytium is linked to early stages of the apoptotic 292 
cascade, with apoptosis-related proteins such as caspase 8 required for fusion [68]. 293 
Regulation of the progression of the apoptotic cascade appears to occur at the mitochondrial 294 
level and involve members of the anti-apoptotic BCL2 family [69]. There is also evidence 295 
that mitochondria are directly involved in the differentiation of cytotrophoblasts into the 296 
syncytiotrophoblast. In primary villous cytotrophoblasts, inhibition of the mitochondrial 297 
respiratory chain leads to a decrease in cell fusion and hormone production (human chorionic 298 
gonadotropin and leptin). Lactate production also appears to be transiently increased during 299 
cytotrophoblast differentiation, suggesting that anaerobic metabolism is important during 300 
differentiation [70].  301 
 302 
6. Mitochondria in preeclampsia and intrauterine growth restriction 303 
 304 
Preeclampsia is a hypertensive disorder of pregnancy characterised by maternal endothelial 305 
dysfunction. Both preeclampsia and IUGR are associated with reduced/intermittent placental 306 
perfusion and increased oxidative stress [3, 71]. As detailed earlier in this review, 307 
preeclampsia and IUGR can lead to changes in placental apoptosis, mitochondrial 308 
fission/fusion, and mitochondrial content (Table 1). Additionally, proteomic analysis of 309 
placental tissue from preeclamptic pregnancies shows the involvement of multiple 310 
mitochondrial-related functions including the tricarboxylic acid cycle, electron transport 311 
chain, fatty acid oxidation, ATP binding, Ca2+ binding, apoptosis, HSP70, and the 312 
mitochondrial antioxidant protein peroxiredoxin III/SP-22 [22, 71-73]. The mitochondria of 313 
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preeclamptic placentae also exhibit swelling and damaged cristae, as well as reduced 314 
expression/activity of mitochondrial complexes and ATP synthase [74-76]. A reduction in 315 
electron flow through complex III and possible damage to other complexes may contribute to 316 
the excess ROS production seen in preeclampsia [74]. Mitochondrial respiration is increased 317 
in early-onset preeclampsia and these mitochondria are also less sensitive to Ca2+ 318 
depolarization, suggesting an adaptive response to oxidative stress [52]. Ca2+ levels are 319 
important in cellular homeostasis and Ca2+ is a critical signalling molecule between 320 
mitochondria and the endoplasmic reticulum [18]. Preeclampsia has been with associated 321 
alterations in intracellular Ca2+ which may affect apoptosis in the placenta [76]. IUGR 322 
independent of preeclampsia leads to changes in mitochondrial content (Table 1), and also 323 
increased mitochondrial respiration in cytotrophoblasts [51]. Maternal food restriction 324 
resulting in fetal growth retardation can lead to changes in placental mitochondrial proteins, 325 
and mitochondria from these placentae have increased oxygen consumption but fail to 326 
maintain ATP production [58]. 327 
 328 
7. Mitochondria in maternal diabetes 329 
  330 
High circulating glucose concentrations in maternal diabetes, which includes both pre-331 
existing diabetes and GDM, may adversely impact on placental function. In individuals with 332 
diabetes, there are ample studies reporting alterations in mitochondrial content, respiratory 333 
function, and complex activity in non-gestational tissues. However, studies examining 334 
specific mitochondrial changes in the placenta are limited. In whole placentae from women 335 
with type 1 diabetes, activity of complexes I and III were reduced and, in type 2 diabetes, 336 
combined activity of complexes II and III were reduced [49]. In the same study, the level of 337 
mitochondrial hydrogen peroxide in placentae was elevated in type 1 diabetes only. This 338 
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aligns with the reductions seen in complex I activity, in being a major source of ROS 339 
production. Placental mitochondrial content remained unaffected in both types of diabetes, 340 
which differs from previous studies in other gestational pathologies, including reduced 341 
mtDNA in preeclampsia and IUGR [51] (Table 1). Previously, Qiu et al. reported that 342 
placental mtDNA copy number was positively associated with a marker of oxidative stress, 8-343 
hydroxy-2′ -deoxyguanosine, in both uncomplicated and GDM pregnancies [77]. There was 344 
no difference in this relationship between non-GDM and GDM placentae, but this study was 345 
carried out in only 40 women and may have been underpowered. In villous tissue from GDM 346 
pregnancies, the expression of mitochondrial complexes was also significantly reduced, but 347 
varied depending on whether women had been treated with diet alone or either insulin or 348 
glyburide [78]. Regardless of treatment, protein expression of PGC1α, the master regulator of 349 
mitochondrial biogenesis, and PPARγ, an important regulator of fatty acid oxidation, were 350 
reduced in placentae from these women with GDM. In a study that examined placental 351 
ultrastructure from 10 women with GDM, mitochondria were found to be swollen or 352 
completely destroyed, and architecturally disrupted [23]. In rats rendered mildly diabetic, 353 
using streptozotocin prior to mating, an increase in mitochondrial membrane fluidity was 354 
observed in placental tissue, along with increases in the ratio of unsaturated to saturated fatty 355 
acids [79]. This was associated with an increase in both placental and fetal weights; however, 356 
a direct cause and effect relationship remains to be tested. Indeed, in humans, placental lipid 357 
metabolism is known to be altered in maternal diabetes [80], but larger cohort studies are 358 
required to clarify the association between placental mitochondrial content, structure, and 359 
function, and adverse fetal outcomes. 360 
 361 
8. Mitochondria in obesity 362 
 363 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
16 
 
Obesity is associated with excess circulating fatty acids, which can affect placental 364 
mitochondrial function [81]. Mitochondrial content, as measured in mitochondrial DNA 365 
amount, is decreased in placentas from obese women, although when measured by citrate 366 
synthase activity, is unaltered [49]. This suggests that despite a lower mitochondrial number, 367 
the oxidative capacity of the mitochondria to produce ATP remains the same.  368 
 369 
The lower mitochondrial content is, however, associated with lower complex I (but not 370 
complex II, III, or IV) activity but higher mitochondrial ROS production [49]. Placental 371 
villous tissues from overweight and obese women have a 6 and 14-fold increase in ROS 372 
production [82] and to a similar extent in male and female offspring. Placental cellular ATP 373 
production, a marker of mitochondrial function, decreases with maternal obesity [82]. This 374 
may be due to decreased placental mitochondrial content as well as reduced expression of 375 
complex I–IV, and this is associated with a decrease in mitochondrial function as measured 376 
by respiration [82]. Similarly, in the placental cell line Swan 71, incubation with palmitate 377 
stimulates overall cellular ROS production as well as mitochondrial ROS production 378 
resulting in reduced secretion of IL-1β, IL-6, and IL-8 [81]. The increases in mitochondrial 379 
ROS production in obesity may result in damaged mitochondrial DNA and thereby decreased 380 
mitochondrial content. Placental mitochondrial content and function have high inter-381 
individual variability in both lean and obese women [49] whilst unclear, (epi)genetic make-382 
up, infant gender, and levels of insulin resistance could contribute to the variability. 383 
 384 
9. Conclusion 385 
 386 
Mitochondria are critical to cellular viability, and mitochondrial function can be disturbed by 387 
variability in oxygen supply. Reduced/interment blood flow to the placenta resulting in 388 
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oxidative stress is thought to be a common feature of several pregnancy complications, and 389 
this oxidative stress is likely to affect placental mitochondria. Indeed, placental mitochondrial 390 
function is altered in a number of pregnancy disorders. Whilst the majority of studies 391 
observed an increase in oxidative stress, the subsequent mitochondrial damage, mitochondrial 392 
bioenergetics, and adaptive responses varied even within the same pathology. Although the 393 
pathophysiology underlying various gestational disorders may be different, alterations in 394 
mitochondrial function and structure are a common terminal pathway and may offer avenues 395 
for the development of therapeutics. However, the mechanisms controlling the mitochondrial 396 
response to stress are complex and require further investigation. 397 
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Table 1. Changes in placental mitochondrial content in pregnancy pathologies. 627 
Pathology Results Publication 
IUGR Increased Lattuada et al. (2008) [44]  
IUGR + PE Increased  
IUGR Decreased Poidatz et al. (2015) [57] 
IUGR + PE Decreased  
IUGR (whole tissue) 
IUGR (cytotrophoblasts) 
Increased1 
Decreased1 
Mando et al. (2014) [51] 
PE No change  
PE Increased  Wang et al. (1998) [73] 
PE Decreased He et al. (2004) [83] 
PE (+IUGR)2 Increased Vishnyakova et al. (2016) [52] 
GDM   No Change Qiu et al. (2013) [84] 
Type I DM  No Change Hastie et al. (2014) [49] 
Type II DM  No Change   
Maternal obesity Decreased  
Maternal obesity Decreased  Mele et al. (2014) [82] 
1Mando et al. (2014) found increased mitochondrial content in whole tissue but decreased 628 
mitochondrial content in isolated cytotrophoblasts 629 
2IUGR reported in 61% of early onset PE and 27% of late onset PE 630 
IUGR=intrauterine growth restriction; PE=preeclampsia; DM=diabetes mellitus; 631 
GDM=gestational diabetes mellitus 632 
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 634 
Figure 1. Model of mitochondrial regulation. Mitochondria form an interconnected 635 
network which is broken apart and reformed by the opposing forces of fission and fusion. 636 
Mitochondria with low membrane potential are targeted for mitophagy (a specialised form of 637 
autophagy targeting mitochondria), mitochondria with high membrane potential are more 638 
likely to fuse with other mitochondria. This balance allows the maintenance of a healthy pool 639 
of mitochondria with high membrane potential. If a large proportion of mitochondria are 640 
depolarised, this may lead to opening of the mitochondrial transition pore, release of inner 641 
membrane components such as cytochrome c, and apoptosis. ∆Ψm=mitochondrial membrane 642 
potential. 643 
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 645 
Figure 2. Control of mitochondrial biogenesis. Mitochondrial biogenesis is regulated by 646 
coordination of the nuclear and mitochondrial genomes. Upregulation of NRF1 leads to 647 
production of TFAM, TFB1M and TFB2M which signal replication of the mitochondrial 648 
genome. NRF1=nuclear respiratory factor 1; TFAM=mitochondrial transcription factor A; 649 
TFB1M=mitochondrial transcription factor B1; TFB2M=mitochondrial transcription factor 650 
B2; mtDNA=mitochondrial DNA; D-loop=displacement loop. 651 
  652 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
26 
 
 653 
Figure 3. Syncytiotrophoblast and cytotrophoblast mitochondria. (A) Cartoon derived 654 
from published electron microscopy images [53, 66] depicting general structural features of 655 
mitochondria from the syncytiotrophoblast and cytotrophoblasts. (B) Mitochondria with the 656 
syncytiotrophoblast are small, and have a non-classical vesicular cristae structure and dense 657 
matrix. (C) Mitochondria with cytotrophoblasts are relatively larger than syncytiotrophoblast 658 
mitochondria and have a more typical cristae structure.  659 
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